English
Segment disclosures
Company overviewTHERMOGENESIS CORP
Each reported dimension combination stays separate. Revenue and operating income are shown as reported, with their dates and sources.
Revenue · Reported segment facts
Counts describe retained dimensioned rows only. Periods and members can change across reports, and this view does not infer missing values or expected segment totals.
Operating Segments · Clinical Development
Consolidation Items · Statement Business Segments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=kool:ClinicalDevelopmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2018-01-01 – 2018-12-31 | 202000 | USD | 2019-03-26 · 18:16:55.000Z | Open filing evidence |
| 2017-07-01 – 2017-12-31 | 186000 | USD | 2019-03-26 · 18:16:55.000Z | Open filing evidence |
| 2016-07-01 – 2017-06-30 | 492000 | USD | 2019-03-26 · 18:16:55.000Z | Open filing evidence |
Operating Segments · Device
Consolidation Items · Statement Business Segments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=kool:DeviceMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2018-01-01 – 2018-12-31 | 9470000 | USD | 2019-03-26 · 18:16:55.000Z | Open filing evidence |
| 2017-07-01 – 2017-12-31 | 5827000 | USD | 2019-03-26 · 18:16:55.000Z | Open filing evidence |
| 2016-07-01 – 2017-06-30 | 14033000 | USD | 2019-03-26 · 18:16:55.000Z | Open filing evidence |
Operating Segments · Clinical Development
Consolidation Items · Statement Business Segments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=thmo:ClinicalDevelopmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2019-01-01 – 2019-12-31 | 12957000 | USD | 20200324 | Open filing evidence |
| 2018-01-01 – 2018-12-31 | 9469000 | USD | 20200324 | Open filing evidence |
Operating Segments · Device
Consolidation Items · Statement Business Segments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=thmo:DeviceMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2019-01-01 – 2019-12-31 | 90000 | USD | 20200324 | Open filing evidence |
| 2018-01-01 – 2018-12-31 | 203000 | USD | 20200324 | Open filing evidence |
Device Revenue · Clinical Development
Product Or Service · Statement Business Segments
Source dimensions
srt:ProductOrServiceAxis=kool:DeviceRevenueMember;us-gaap:StatementBusinessSegmentsAxis=kool:ClinicalDevelopmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2018-01-01 – 2018-12-31 | 38000 | USD | 2019-03-26 · 18:16:55.000Z | Open filing evidence |
Device Revenue · Clinical Development · Other Subsegments
Product Or Service · Statement Business Segments · Subsegments
Source dimensions
srt:ProductOrServiceAxis=kool:DeviceRevenueMember;us-gaap:StatementBusinessSegmentsAxis=kool:ClinicalDevelopmentMember;us-gaap:SubsegmentsAxis=kool:OtherSubsegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2018-01-01 – 2018-12-31 | 38000 | USD | 2019-03-26 · 18:16:55.000Z | Open filing evidence |
Device Revenue · Device
Product Or Service · Statement Business Segments
Source dimensions
srt:ProductOrServiceAxis=kool:DeviceRevenueMember;us-gaap:StatementBusinessSegmentsAxis=kool:DeviceMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2018-01-01 – 2018-12-31 | 7806000 | USD | 2019-03-26 · 18:16:55.000Z | Open filing evidence |
Device Revenue · Device · Axp
Product Or Service · Statement Business Segments · Subsegments
Source dimensions
srt:ProductOrServiceAxis=kool:DeviceRevenueMember;us-gaap:StatementBusinessSegmentsAxis=kool:DeviceMember;us-gaap:SubsegmentsAxis=kool:AxpMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2018-01-01 – 2018-12-31 | 4131000 | USD | 2019-03-26 · 18:16:55.000Z | Open filing evidence |
Device Revenue · Device · Bioarchive
Product Or Service · Statement Business Segments · Subsegments
Source dimensions
srt:ProductOrServiceAxis=kool:DeviceRevenueMember;us-gaap:StatementBusinessSegmentsAxis=kool:DeviceMember;us-gaap:SubsegmentsAxis=kool:BioarchiveMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2018-01-01 – 2018-12-31 | 1792000 | USD | 2019-03-26 · 18:16:55.000Z | Open filing evidence |
Device Revenue · Device · CART Xpress
Product Or Service · Statement Business Segments · Subsegments
Source dimensions
srt:ProductOrServiceAxis=kool:DeviceRevenueMember;us-gaap:StatementBusinessSegmentsAxis=kool:DeviceMember;us-gaap:SubsegmentsAxis=kool:CARTXpressMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2018-01-01 – 2018-12-31 | 907000 | USD | 2019-03-26 · 18:16:55.000Z | Open filing evidence |
Device Revenue · Device · Manual Disposables
Product Or Service · Statement Business Segments · Subsegments
Source dimensions
srt:ProductOrServiceAxis=kool:DeviceRevenueMember;us-gaap:StatementBusinessSegmentsAxis=kool:DeviceMember;us-gaap:SubsegmentsAxis=kool:ManualDisposablesMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2018-01-01 – 2018-12-31 | 976000 | USD | 2019-03-26 · 18:16:55.000Z | Open filing evidence |
Other · Device
Product Or Service · Statement Business Segments
Source dimensions
srt:ProductOrServiceAxis=kool:OtherMember;us-gaap:StatementBusinessSegmentsAxis=kool:DeviceMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2018-01-01 – 2018-12-31 | 95000 | USD | 2019-03-26 · 18:16:55.000Z | Open filing evidence |
Other · Device · Other Subsegments
Product Or Service · Statement Business Segments · Subsegments
Source dimensions
srt:ProductOrServiceAxis=kool:OtherMember;us-gaap:StatementBusinessSegmentsAxis=kool:DeviceMember;us-gaap:SubsegmentsAxis=kool:OtherSubsegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2018-01-01 – 2018-12-31 | 95000 | USD | 2019-03-26 · 18:16:55.000Z | Open filing evidence |
Device Revenue · Clinical Development
Product Or Service · Statement Business Segments
Source dimensions
srt:ProductOrServiceAxis=thmo:DeviceRevenueMember;us-gaap:StatementBusinessSegmentsAxis=thmo:ClinicalDevelopmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2019-01-01 – 2019-12-31 | 68000 | USD | 20200324 | Open filing evidence |
| 2018-01-01 – 2018-12-31 | 38000 | USD | 20200324 | Open filing evidence |
Device Revenue · Clinical Development · Manual Disposables
Product Or Service · Statement Business Segments · Subsegments
Source dimensions
srt:ProductOrServiceAxis=thmo:DeviceRevenueMember;us-gaap:StatementBusinessSegmentsAxis=thmo:ClinicalDevelopmentMember;us-gaap:SubsegmentsAxis=thmo:ManualDisposablesMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2019-01-01 – 2019-12-31 | 68000 | USD | 20200324 | Open filing evidence |
Device Revenue · Clinical Development · Other Subsegments
Product Or Service · Statement Business Segments · Subsegments
Source dimensions
srt:ProductOrServiceAxis=thmo:DeviceRevenueMember;us-gaap:StatementBusinessSegmentsAxis=thmo:ClinicalDevelopmentMember;us-gaap:SubsegmentsAxis=thmo:OtherSubsegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2018-01-01 – 2018-12-31 | 38000 | USD | 20200324 | Open filing evidence |
Device Revenue · Device
Product Or Service · Statement Business Segments
Source dimensions
srt:ProductOrServiceAxis=thmo:DeviceRevenueMember;us-gaap:StatementBusinessSegmentsAxis=thmo:DeviceMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2019-01-01 – 2019-12-31 | 11151000 | USD | 20200324 | Open filing evidence |
| 2018-01-01 – 2018-12-31 | 7806000 | USD | 20200324 | Open filing evidence |
Device Revenue · Device · Axp
Product Or Service · Statement Business Segments · Subsegments
Source dimensions
srt:ProductOrServiceAxis=thmo:DeviceRevenueMember;us-gaap:StatementBusinessSegmentsAxis=thmo:DeviceMember;us-gaap:SubsegmentsAxis=thmo:AxpMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2020-01-01 – 2020-12-31 | 4774000 | USD | 20210317 | Open filing evidence |
| 2020-07-01 – 2020-09-30 | 1137000 | USD | 20201112 | Open filing evidence |
| 2020-01-01 – 2020-09-30 | 4009000 | USD | 20201112 | Open filing evidence |
| 2020-04-01 – 2020-06-30 | 621000 | USD | 20200814 | Open filing evidence |
| 2020-01-01 – 2020-06-30 | 2829000 | USD | 20200814 | Open filing evidence |
| 2020-01-01 – 2020-03-31 | 2208000 | USD | 20200515 | Open filing evidence |
| 2019-01-01 – 2019-12-31 | 7313000 | USD | 20210317 | Open filing evidence |
| 2019-07-01 – 2019-09-30 | 2255000 | USD | 20201112 | Open filing evidence |
| 2019-01-01 – 2019-09-30 | 6550000 | USD | 20201112 | Open filing evidence |
| 2019-04-01 – 2019-06-30 | 3028000 | USD | 20200814 | Open filing evidence |
| 2019-01-01 – 2019-06-30 | 4295000 | USD | 20200814 | Open filing evidence |
| 2019-01-01 – 2019-03-31 | 1267000 | USD | 20200515 | Open filing evidence |
| 2018-01-01 – 2018-12-31 | 4131000 | USD | 20200324 | Open filing evidence |
Device Revenue · Device · Bioarchive
Product Or Service · Statement Business Segments · Subsegments
Source dimensions
srt:ProductOrServiceAxis=thmo:DeviceRevenueMember;us-gaap:StatementBusinessSegmentsAxis=thmo:DeviceMember;us-gaap:SubsegmentsAxis=thmo:BioarchiveMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2020-01-01 – 2020-12-31 | 855000 | USD | 20210317 | Open filing evidence |
| 2020-07-01 – 2020-09-30 | 337000 | USD | 20201112 | Open filing evidence |
| 2020-01-01 – 2020-09-30 | 675000 | USD | 20201112 | Open filing evidence |
| 2020-04-01 – 2020-06-30 | 165000 | USD | 20200814 | Open filing evidence |
| 2020-01-01 – 2020-06-30 | 329000 | USD | 20200814 | Open filing evidence |
| 2020-01-01 – 2020-03-31 | 164000 | USD | 20200515 | Open filing evidence |
| 2019-01-01 – 2019-12-31 | 1472000 | USD | 20210317 | Open filing evidence |
| 2019-07-01 – 2019-09-30 | 243000 | USD | 20201112 | Open filing evidence |
| 2019-01-01 – 2019-09-30 | 1274000 | USD | 20201112 | Open filing evidence |
| 2019-04-01 – 2019-06-30 | 433000 | USD | 20200814 | Open filing evidence |
| 2019-01-01 – 2019-06-30 | 1031000 | USD | 20200814 | Open filing evidence |
| 2019-01-01 – 2019-03-31 | 599000 | USD | 20200515 | Open filing evidence |
| 2018-01-01 – 2018-12-31 | 1792000 | USD | 20200324 | Open filing evidence |
Device Revenue · Device · CART Xpress
Product Or Service · Statement Business Segments · Subsegments
Source dimensions
srt:ProductOrServiceAxis=thmo:DeviceRevenueMember;us-gaap:StatementBusinessSegmentsAxis=thmo:DeviceMember;us-gaap:SubsegmentsAxis=thmo:CARTXpressMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2020-01-01 – 2020-12-31 | 1471000 | USD | 20210317 | Open filing evidence |
| 2020-07-01 – 2020-09-30 | 332000 | USD | 20201112 | Open filing evidence |
| 2020-01-01 – 2020-09-30 | 1035000 | USD | 20201112 | Open filing evidence |
| 2020-04-01 – 2020-06-30 | 550000 | USD | 20200814 | Open filing evidence |
| 2020-01-01 – 2020-06-30 | 702000 | USD | 20200814 | Open filing evidence |
| 2020-01-01 – 2020-03-31 | 152000 | USD | 20200515 | Open filing evidence |
| 2019-01-01 – 2019-12-31 | 1457000 | USD | 20210317 | Open filing evidence |
| 2019-07-01 – 2019-09-30 | 875000 | USD | 20201112 | Open filing evidence |
| 2019-01-01 – 2019-09-30 | 1365000 | USD | 20201112 | Open filing evidence |
| 2019-04-01 – 2019-06-30 | 182000 | USD | 20200814 | Open filing evidence |
| 2019-01-01 – 2019-06-30 | 490000 | USD | 20200814 | Open filing evidence |
| 2019-01-01 – 2019-03-31 | 307000 | USD | 20200515 | Open filing evidence |
| 2018-01-01 – 2018-12-31 | 907000 | USD | 20200324 | Open filing evidence |
Device Revenue · Device · Manual Disposables
Product Or Service · Statement Business Segments · Subsegments
Source dimensions
srt:ProductOrServiceAxis=thmo:DeviceRevenueMember;us-gaap:StatementBusinessSegmentsAxis=thmo:DeviceMember;us-gaap:SubsegmentsAxis=thmo:ManualDisposablesMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2020-01-01 – 2020-12-31 | 599000 | USD | 20210317 | Open filing evidence |
| 2020-07-01 – 2020-09-30 | 100000 | USD | 20201112 | Open filing evidence |
| 2020-01-01 – 2020-09-30 | 499000 | USD | 20201112 | Open filing evidence |
| 2020-04-01 – 2020-06-30 | 198000 | USD | 20200814 | Open filing evidence |
| 2020-01-01 – 2020-06-30 | 401000 | USD | 20200814 | Open filing evidence |
| 2020-01-01 – 2020-03-31 | 203000 | USD | 20200515 | Open filing evidence |
| 2019-01-01 – 2019-12-31 | 977000 Restated | USD | 20210317 | Open filing evidence |
| 2019-07-01 – 2019-09-30 | 221000 | USD | 20201112 | Open filing evidence |
| 2019-01-01 – 2019-09-30 | 764000 | USD | 20201112 | Open filing evidence |
| 2019-04-01 – 2019-06-30 | 242000 | USD | 20200814 | Open filing evidence |
| 2019-01-01 – 2019-06-30 | 543000 | USD | 20200814 | Open filing evidence |
| 2019-01-01 – 2019-03-31 | 300000 | USD | 20200515 | Open filing evidence |
| 2018-01-01 – 2018-12-31 | 976000 | USD | 20200324 | Open filing evidence |
Device Revenue · Device · Other Subsegments
Product Or Service · Statement Business Segments · Subsegments
Source dimensions
srt:ProductOrServiceAxis=thmo:DeviceRevenueMember;us-gaap:StatementBusinessSegmentsAxis=thmo:DeviceMember;us-gaap:SubsegmentsAxis=thmo:OtherSubsegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2020-01-01 – 2020-12-31 | 289000 | USD | 20210317 | Open filing evidence |
| 2020-07-01 – 2020-09-30 | 26000 | USD | 20201112 | Open filing evidence |
| 2020-01-01 – 2020-09-30 | 276000 | USD | 20201112 | Open filing evidence |
| 2020-04-01 – 2020-06-30 | 238000 | USD | 20200814 | Open filing evidence |
| 2020-01-01 – 2020-06-30 | 252000 | USD | 20200814 | Open filing evidence |
| 2020-01-01 – 2020-03-31 | 14000 | USD | 20200515 | Open filing evidence |
| 2019-01-01 – 2019-09-30 | 5000 | USD | 20201112 | Open filing evidence |
| 2019-01-01 – 2019-06-30 | 5000 | USD | 20200814 | Open filing evidence |
| 2019-01-01 – 2019-03-31 | 5000 | USD | 20200515 | Open filing evidence |
Other · Device
Product Or Service · Statement Business Segments
Source dimensions
srt:ProductOrServiceAxis=thmo:OtherMember;us-gaap:StatementBusinessSegmentsAxis=thmo:DeviceMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2019-01-01 – 2019-12-31 | 146000 | USD | 20200324 | Open filing evidence |
| 2018-01-01 – 2018-12-31 | 95000 | USD | 20200324 | Open filing evidence |
Other · Device · CART Xpress
Product Or Service · Statement Business Segments · Subsegments
Source dimensions
srt:ProductOrServiceAxis=thmo:OtherMember;us-gaap:StatementBusinessSegmentsAxis=thmo:DeviceMember;us-gaap:SubsegmentsAxis=thmo:CARTXpressMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2020-01-01 – 2020-12-31 | 286000 | USD | 20210317 | Open filing evidence |
| 2020-07-01 – 2020-09-30 | 71000 | USD | 20201112 | Open filing evidence |
| 2020-01-01 – 2020-09-30 | 214000 | USD | 20201112 | Open filing evidence |
| 2020-04-01 – 2020-06-30 | 71000 | USD | 20200814 | Open filing evidence |
| 2020-01-01 – 2020-06-30 | 142000 | USD | 20200814 | Open filing evidence |
| 2020-01-01 – 2020-03-31 | 71000 | USD | 20200515 | Open filing evidence |
| 2019-01-01 – 2019-12-31 | 95000 | USD | 20210317 | Open filing evidence |
| 2019-07-01 – 2019-09-30 | 33000 | USD | 20201112 | Open filing evidence |
| 2019-01-01 – 2019-09-30 | 33000 | USD | 20201112 | Open filing evidence |
Other · Device · Other Subsegments
Product Or Service · Statement Business Segments · Subsegments
Source dimensions
srt:ProductOrServiceAxis=thmo:OtherMember;us-gaap:StatementBusinessSegmentsAxis=thmo:DeviceMember;us-gaap:SubsegmentsAxis=thmo:OtherSubsegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2020-01-01 – 2020-12-31 | 62000 | USD | 20210317 | Open filing evidence |
| 2020-07-01 – 2020-09-30 | 16000 | USD | 20201112 | Open filing evidence |
| 2020-01-01 – 2020-09-30 | 39000 | USD | 20201112 | Open filing evidence |
| 2020-04-01 – 2020-06-30 | 44000 | USD | 20200814 | Open filing evidence |
| 2020-01-01 – 2020-06-30 | 64000 | USD | 20200814 | Open filing evidence |
| 2020-01-01 – 2020-03-31 | 20000 | USD | 20200515 | Open filing evidence |
| 2019-01-01 – 2019-12-31 | 51000 | USD | 20210317 | Open filing evidence |
| 2019-07-01 – 2019-09-30 | 19000 | USD | 20201112 | Open filing evidence |
| 2019-01-01 – 2019-09-30 | 40000 | USD | 20201112 | Open filing evidence |
| 2019-04-01 – 2019-06-30 | 8000 | USD | 20200814 | Open filing evidence |
| 2019-01-01 – 2019-06-30 | 22000 | USD | 20200814 | Open filing evidence |
| 2019-01-01 – 2019-03-31 | 14000 | USD | 20200515 | Open filing evidence |
| 2018-01-01 – 2018-12-31 | 95000 | USD | 20200324 | Open filing evidence |
Service · Clinical Development
Product Or Service · Statement Business Segments
Source dimensions
srt:ProductOrServiceAxis=us-gaap:ServiceMember;us-gaap:StatementBusinessSegmentsAxis=kool:ClinicalDevelopmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2018-01-01 – 2018-12-31 | 165000 | USD | 2019-03-26 · 18:16:55.000Z | Open filing evidence |
Service · Clinical Development · Bone Marrow
Product Or Service · Statement Business Segments · Subsegments
Source dimensions
srt:ProductOrServiceAxis=us-gaap:ServiceMember;us-gaap:StatementBusinessSegmentsAxis=kool:ClinicalDevelopmentMember;us-gaap:SubsegmentsAxis=kool:BoneMarrowMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2018-01-01 – 2018-12-31 | 135000 | USD | 2019-03-26 · 18:16:55.000Z | Open filing evidence |
Service · Clinical Development · Other Subsegments
Product Or Service · Statement Business Segments · Subsegments
Source dimensions
srt:ProductOrServiceAxis=us-gaap:ServiceMember;us-gaap:StatementBusinessSegmentsAxis=kool:ClinicalDevelopmentMember;us-gaap:SubsegmentsAxis=kool:OtherSubsegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2018-01-01 – 2018-12-31 | 30000 | USD | 2019-03-26 · 18:16:55.000Z | Open filing evidence |
Service · Device
Product Or Service · Statement Business Segments
Source dimensions
srt:ProductOrServiceAxis=us-gaap:ServiceMember;us-gaap:StatementBusinessSegmentsAxis=kool:DeviceMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2018-01-01 – 2018-12-31 | 1568000 | USD | 2019-03-26 · 18:16:55.000Z | Open filing evidence |
Service · Device · Axp
Product Or Service · Statement Business Segments · Subsegments
Source dimensions
srt:ProductOrServiceAxis=us-gaap:ServiceMember;us-gaap:StatementBusinessSegmentsAxis=kool:DeviceMember;us-gaap:SubsegmentsAxis=kool:AxpMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2018-01-01 – 2018-12-31 | 262000 | USD | 2019-03-26 · 18:16:55.000Z | Open filing evidence |
Service · Device · Bioarchive
Product Or Service · Statement Business Segments · Subsegments
Source dimensions
srt:ProductOrServiceAxis=us-gaap:ServiceMember;us-gaap:StatementBusinessSegmentsAxis=kool:DeviceMember;us-gaap:SubsegmentsAxis=kool:BioarchiveMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2018-01-01 – 2018-12-31 | 1306000 | USD | 2019-03-26 · 18:16:55.000Z | Open filing evidence |
Service · Clinical Development
Product Or Service · Statement Business Segments
Source dimensions
srt:ProductOrServiceAxis=us-gaap:ServiceMember;us-gaap:StatementBusinessSegmentsAxis=thmo:ClinicalDevelopmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2019-01-01 – 2019-12-31 | 22000 | USD | 20200324 | Open filing evidence |
| 2018-01-01 – 2018-12-31 | 165000 | USD | 20200324 | Open filing evidence |
Service · Clinical Development · Bone Marrow
Product Or Service · Statement Business Segments · Subsegments
Source dimensions
srt:ProductOrServiceAxis=us-gaap:ServiceMember;us-gaap:StatementBusinessSegmentsAxis=thmo:ClinicalDevelopmentMember;us-gaap:SubsegmentsAxis=thmo:BoneMarrowMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2018-01-01 – 2018-12-31 | 135000 | USD | 20200324 | Open filing evidence |
Service · Clinical Development · Other Subsegments
Product Or Service · Statement Business Segments · Subsegments
Source dimensions
srt:ProductOrServiceAxis=us-gaap:ServiceMember;us-gaap:StatementBusinessSegmentsAxis=thmo:ClinicalDevelopmentMember;us-gaap:SubsegmentsAxis=thmo:OtherSubsegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2019-01-01 – 2019-12-31 | 22000 | USD | 20200324 | Open filing evidence |
| 2018-01-01 – 2018-12-31 | 30000 | USD | 20200324 | Open filing evidence |
Service · Device
Product Or Service · Statement Business Segments
Source dimensions
srt:ProductOrServiceAxis=us-gaap:ServiceMember;us-gaap:StatementBusinessSegmentsAxis=thmo:DeviceMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2019-01-01 – 2019-12-31 | 1660000 | USD | 20200324 | Open filing evidence |
| 2018-01-01 – 2018-12-31 | 1568000 | USD | 20200324 | Open filing evidence |
Service · Device · Axp
Product Or Service · Statement Business Segments · Subsegments
Source dimensions
srt:ProductOrServiceAxis=us-gaap:ServiceMember;us-gaap:StatementBusinessSegmentsAxis=thmo:DeviceMember;us-gaap:SubsegmentsAxis=thmo:AxpMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2020-01-01 – 2020-12-31 | 160000 | USD | 20210317 | Open filing evidence |
| 2020-07-01 – 2020-09-30 | 32000 | USD | 20201112 | Open filing evidence |
| 2020-01-01 – 2020-09-30 | 103000 | USD | 20201112 | Open filing evidence |
| 2020-04-01 – 2020-06-30 | 48000 | USD | 20200814 | Open filing evidence |
| 2020-01-01 – 2020-06-30 | 72000 | USD | 20200814 | Open filing evidence |
| 2020-01-01 – 2020-03-31 | 24000 | USD | 20200515 | Open filing evidence |
| 2019-01-01 – 2019-12-31 | 209000 | USD | 20210317 | Open filing evidence |
| 2019-07-01 – 2019-09-30 | 51000 | USD | 20201112 | Open filing evidence |
| 2019-01-01 – 2019-09-30 | 160000 | USD | 20201112 | Open filing evidence |
| 2019-04-01 – 2019-06-30 | 54000 | USD | 20200814 | Open filing evidence |
| 2019-01-01 – 2019-06-30 | 109000 | USD | 20200814 | Open filing evidence |
| 2019-01-01 – 2019-03-31 | 55000 | USD | 20200515 | Open filing evidence |
| 2018-01-01 – 2018-12-31 | 262000 | USD | 20200324 | Open filing evidence |
Service · Device · Bioarchive
Product Or Service · Statement Business Segments · Subsegments
Source dimensions
srt:ProductOrServiceAxis=us-gaap:ServiceMember;us-gaap:StatementBusinessSegmentsAxis=thmo:DeviceMember;us-gaap:SubsegmentsAxis=thmo:BioarchiveMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2020-01-01 – 2020-12-31 | 1177000 | USD | 20210317 | Open filing evidence |
| 2020-07-01 – 2020-09-30 | 282000 | USD | 20201112 | Open filing evidence |
| 2020-01-01 – 2020-09-30 | 900000 | USD | 20201112 | Open filing evidence |
| 2020-04-01 – 2020-06-30 | 294000 | USD | 20200814 | Open filing evidence |
| 2020-01-01 – 2020-06-30 | 626000 | USD | 20200814 | Open filing evidence |
| 2020-01-01 – 2020-03-31 | 332000 | USD | 20200515 | Open filing evidence |
| 2019-01-01 – 2019-12-31 | 1438000 | USD | 20210317 | Open filing evidence |
| 2019-07-01 – 2019-09-30 | 351000 | USD | 20201112 | Open filing evidence |
| 2019-01-01 – 2019-09-30 | 1117000 | USD | 20201112 | Open filing evidence |
| 2019-04-01 – 2019-06-30 | 351000 | USD | 20200814 | Open filing evidence |
| 2019-01-01 – 2019-06-30 | 766000 | USD | 20200814 | Open filing evidence |
| 2019-01-01 – 2019-03-31 | 415000 | USD | 20200515 | Open filing evidence |
| 2018-01-01 – 2018-12-31 | 1306000 | USD | 20200324 | Open filing evidence |
Service · Device · CART Xpress
Product Or Service · Statement Business Segments · Subsegments
Source dimensions
srt:ProductOrServiceAxis=us-gaap:ServiceMember;us-gaap:StatementBusinessSegmentsAxis=thmo:DeviceMember;us-gaap:SubsegmentsAxis=thmo:CARTXpressMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2020-01-01 – 2020-12-31 | 71000 | USD | 20210317 | Open filing evidence |
| 2020-07-01 – 2020-09-30 | 22000 | USD | 20201112 | Open filing evidence |
| 2020-01-01 – 2020-09-30 | 47000 | USD | 20201112 | Open filing evidence |
| 2020-04-01 – 2020-06-30 | 13000 | USD | 20200814 | Open filing evidence |
| 2020-01-01 – 2020-06-30 | 25000 | USD | 20200814 | Open filing evidence |
| 2020-01-01 – 2020-03-31 | 12000 | USD | 20200515 | Open filing evidence |
| 2019-01-01 – 2019-12-31 | 13000 | USD | 20210317 | Open filing evidence |
| 2019-07-01 – 2019-09-30 | 10000 | USD | 20201112 | Open filing evidence |
| 2019-01-01 – 2019-09-30 | 6000 | USD | 20201112 | Open filing evidence |
Service · Device · Other Subsegments
Product Or Service · Statement Business Segments · Subsegments
Source dimensions
srt:ProductOrServiceAxis=us-gaap:ServiceMember;us-gaap:StatementBusinessSegmentsAxis=thmo:DeviceMember;us-gaap:SubsegmentsAxis=thmo:OtherSubsegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2019-01-01 – 2019-12-31 | 22000 Restated | USD | 20210317 | Open filing evidence |
| 2019-01-01 – 2019-09-30 | 11000 | USD | 20201112 | Open filing evidence |
| 2019-04-01 – 2019-06-30 | 7000 | USD | 20200814 | Open filing evidence |
| 2019-01-01 – 2019-06-30 | 7000 | USD | 20200814 | Open filing evidence |
Product Concentration Risk · Axp
Concentration Risk By Type · Statement Business Segments
Source dimensions
us-gaap:ConcentrationRiskByTypeAxis=us-gaap:ProductConcentrationRiskMember;us-gaap:StatementBusinessSegmentsAxis=kool:AxpMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2016-07-01 – 2017-06-30 | 8715000 | USD | 2017-09-22 · 00:05:37.000Z | Open filing evidence |
| 2015-07-01 – 2016-06-30 | 6932000 | USD | 2017-09-22 · 00:05:37.000Z | Open filing evidence |
| 2014-07-01 – 2015-06-30 | 6612000 | USD | 20160921 | Open filing evidence |
| 2013-07-01 – 2014-06-30 | 6143000 | USD | 20150917 | Open filing evidence |
Product Concentration Risk · Bioarchive
Concentration Risk By Type · Statement Business Segments
Source dimensions
us-gaap:ConcentrationRiskByTypeAxis=us-gaap:ProductConcentrationRiskMember;us-gaap:StatementBusinessSegmentsAxis=kool:BioarchiveMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2016-07-01 – 2017-06-30 | 3318000 | USD | 2017-09-22 · 00:05:37.000Z | Open filing evidence |
| 2015-07-01 – 2016-06-30 | 2465000 | USD | 2017-09-22 · 00:05:37.000Z | Open filing evidence |
| 2014-07-01 – 2015-06-30 | 4241000 | USD | 20160921 | Open filing evidence |
| 2013-07-01 – 2014-06-30 | 4776000 | USD | 20150917 | Open filing evidence |
Product Concentration Risk · Bone Marrow
Concentration Risk By Type · Statement Business Segments
Source dimensions
us-gaap:ConcentrationRiskByTypeAxis=us-gaap:ProductConcentrationRiskMember;us-gaap:StatementBusinessSegmentsAxis=kool:BoneMarrowMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2016-07-01 – 2017-06-30 | 745000 | USD | 2017-09-22 · 00:05:37.000Z | Open filing evidence |
| 2015-07-01 – 2016-06-30 | 459000 | USD | 2017-09-22 · 00:05:37.000Z | Open filing evidence |
| 2014-07-01 – 2015-06-30 | 2621000 | USD | 20160921 | Open filing evidence |
| 2013-07-01 – 2014-06-30 | 2542000 | USD | 20150917 | Open filing evidence |
Product Concentration Risk · Manual Disposables
Concentration Risk By Type · Statement Business Segments
Source dimensions
us-gaap:ConcentrationRiskByTypeAxis=us-gaap:ProductConcentrationRiskMember;us-gaap:StatementBusinessSegmentsAxis=kool:ManualDisposablesMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2016-07-01 – 2017-06-30 | 1195000 | USD | 2017-09-22 · 00:05:37.000Z | Open filing evidence |
| 2015-07-01 – 2016-06-30 | 1507000 | USD | 2017-09-22 · 00:05:37.000Z | Open filing evidence |
| 2014-07-01 – 2015-06-30 | 1810000 | USD | 20160921 | Open filing evidence |
| 2013-07-01 – 2014-06-30 | 1706000 | USD | 20150917 | Open filing evidence |
Product Concentration Risk · All Other Segments
Concentration Risk By Type · Statement Business Segments
Source dimensions
us-gaap:ConcentrationRiskByTypeAxis=us-gaap:ProductConcentrationRiskMember;us-gaap:StatementBusinessSegmentsAxis=us-gaap:AllOtherSegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2016-07-01 – 2017-06-30 | 552000 | USD | 2017-09-22 · 00:05:37.000Z | Open filing evidence |
| 2015-07-01 – 2016-06-30 | 566000 | USD | 2017-09-22 · 00:05:37.000Z | Open filing evidence |
| 2014-07-01 – 2015-06-30 | 758000 | USD | 20160921 | Open filing evidence |
| 2013-07-01 – 2014-06-30 | 820000 | USD | 20150917 | Open filing evidence |
Operating Segments · Clinical Development
Consolidation Items · Statement Business Segments
Source dimensions
us-gaap:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=kool:ClinicalDevelopmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2017-07-01 – 2017-09-30 | 126000 | USD | 2017-11-14 · 21:41:47.000Z | Open filing evidence |
Operating Segments · Clinical Protocols
Consolidation Items · Statement Business Segments
Source dimensions
us-gaap:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=kool:ClinicalProtocolsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2016-07-01 – 2016-09-30 | 156000 | USD | 2017-11-14 · 21:41:47.000Z | Open filing evidence |
Operating Segments · Device
Consolidation Items · Statement Business Segments
Source dimensions
us-gaap:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=kool:DeviceMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2017-07-01 – 2017-09-30 | 2943000 | USD | 2017-11-14 · 21:41:47.000Z | Open filing evidence |
Operating Segments · Device Registration
Consolidation Items · Statement Business Segments
Source dimensions
us-gaap:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=kool:DeviceRegistrationMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2016-07-01 – 2016-09-30 | 3611000 | USD | 2017-11-14 · 21:41:47.000Z | Open filing evidence |
Clinical Development
Statement Business Segments
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=kool:ClinicalDevelopmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2018-01-01 – 2018-12-31 | 203000 | USD | 2019-03-26 · 18:16:55.000Z | Open filing evidence |
| 2016-07-01 – 2017-06-30 | 492000 | USD | 2017-09-22 · 00:05:37.000Z | Open filing evidence |
Clinical Development · Bone Marrow
Statement Business Segments · Subsegments
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=kool:ClinicalDevelopmentMember;us-gaap:SubsegmentsAxis=kool:BoneMarrowMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2018-01-01 – 2018-12-31 | 135000 | USD | 2019-03-26 · 18:16:55.000Z | Open filing evidence |
Clinical Development · Other Subsegments
Statement Business Segments · Subsegments
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=kool:ClinicalDevelopmentMember;us-gaap:SubsegmentsAxis=kool:OtherSubsegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2018-01-01 – 2018-12-31 | 68000 | USD | 2019-03-26 · 18:16:55.000Z | Open filing evidence |
Clinical Protocols
Statement Business Segments
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=kool:ClinicalProtocolsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2015-07-01 – 2016-06-30 | 646000 | USD | 2017-09-22 · 00:05:37.000Z | Open filing evidence |
Device
Statement Business Segments
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=kool:DeviceMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2018-01-01 – 2018-12-31 | 9469000 | USD | 2019-03-26 · 18:16:55.000Z | Open filing evidence |
| 2016-07-01 – 2017-06-30 | 14033000 | USD | 2017-09-22 · 00:05:37.000Z | Open filing evidence |
Device · Axp
Statement Business Segments · Subsegments
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=kool:DeviceMember;us-gaap:SubsegmentsAxis=kool:AxpMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2018-01-01 – 2018-12-31 | 4393000 | USD | 2019-03-26 · 18:16:55.000Z | Open filing evidence |
Device · Bioarchive
Statement Business Segments · Subsegments
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=kool:DeviceMember;us-gaap:SubsegmentsAxis=kool:BioarchiveMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2018-01-01 – 2018-12-31 | 3098000 | USD | 2019-03-26 · 18:16:55.000Z | Open filing evidence |
Device · CART Xpress
Statement Business Segments · Subsegments
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=kool:DeviceMember;us-gaap:SubsegmentsAxis=kool:CARTXpressMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2018-01-01 – 2018-12-31 | 907000 | USD | 2019-03-26 · 18:16:55.000Z | Open filing evidence |
Device · Manual Disposables
Statement Business Segments · Subsegments
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=kool:DeviceMember;us-gaap:SubsegmentsAxis=kool:ManualDisposablesMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2018-01-01 – 2018-12-31 | 976000 | USD | 2019-03-26 · 18:16:55.000Z | Open filing evidence |
Device · Other Subsegments
Statement Business Segments · Subsegments
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=kool:DeviceMember;us-gaap:SubsegmentsAxis=kool:OtherSubsegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2018-01-01 – 2018-12-31 | 95000 | USD | 2019-03-26 · 18:16:55.000Z | Open filing evidence |
Device Registration
Statement Business Segments
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=kool:DeviceRegistrationMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2015-07-01 – 2016-06-30 | 11283000 | USD | 2017-09-22 · 00:05:37.000Z | Open filing evidence |
Clinical Development
Statement Business Segments
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=thmo:ClinicalDevelopmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2019-01-01 – 2019-12-31 | 90000 | USD | 20200324 | Open filing evidence |
| 2018-01-01 – 2018-12-31 | 203000 | USD | 20200324 | Open filing evidence |
Clinical Development · Bone Marrow
Statement Business Segments · Subsegments
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=thmo:ClinicalDevelopmentMember;us-gaap:SubsegmentsAxis=thmo:BoneMarrowMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2018-01-01 – 2018-12-31 | 135000 | USD | 20200324 | Open filing evidence |
Clinical Development · Manual Disposables
Statement Business Segments · Subsegments
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=thmo:ClinicalDevelopmentMember;us-gaap:SubsegmentsAxis=thmo:ManualDisposablesMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2019-01-01 – 2019-12-31 | 68000 | USD | 20200324 | Open filing evidence |
Clinical Development · Other Subsegments
Statement Business Segments · Subsegments
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=thmo:ClinicalDevelopmentMember;us-gaap:SubsegmentsAxis=thmo:OtherSubsegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2019-01-01 – 2019-12-31 | 22000 | USD | 20200324 | Open filing evidence |
| 2018-01-01 – 2018-12-31 | 68000 | USD | 20200324 | Open filing evidence |
Device
Statement Business Segments
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=thmo:DeviceMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2019-01-01 – 2019-12-31 | 12957000 | USD | 20200324 | Open filing evidence |
| 2018-01-01 – 2018-12-31 | 9469000 | USD | 20200324 | Open filing evidence |
Device · Axp
Statement Business Segments · Subsegments
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=thmo:DeviceMember;us-gaap:SubsegmentsAxis=thmo:AxpMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2020-01-01 – 2020-12-31 | 4934000 | USD | 20210317 | Open filing evidence |
| 2020-07-01 – 2020-09-30 | 1169000 | USD | 20201112 | Open filing evidence |
| 2020-01-01 – 2020-09-30 | 4112000 | USD | 20201112 | Open filing evidence |
| 2020-04-01 – 2020-06-30 | 669000 | USD | 20200814 | Open filing evidence |
| 2020-01-01 – 2020-06-30 | 2901000 | USD | 20200814 | Open filing evidence |
| 2020-01-01 – 2020-03-31 | 2232000 | USD | 20200515 | Open filing evidence |
| 2019-01-01 – 2019-12-31 | 7522000 | USD | 20210317 | Open filing evidence |
| 2019-07-01 – 2019-09-30 | 2306000 | USD | 20201112 | Open filing evidence |
| 2019-01-01 – 2019-09-30 | 6710000 | USD | 20201112 | Open filing evidence |
| 2019-04-01 – 2019-06-30 | 3082000 | USD | 20200814 | Open filing evidence |
| 2019-01-01 – 2019-06-30 | 4404000 | USD | 20200814 | Open filing evidence |
| 2019-01-01 – 2019-03-31 | 1322000 | USD | 20200515 | Open filing evidence |
| 2018-01-01 – 2018-12-31 | 4393000 | USD | 20200324 | Open filing evidence |
Device · Bioarchive
Statement Business Segments · Subsegments
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=thmo:DeviceMember;us-gaap:SubsegmentsAxis=thmo:BioarchiveMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2020-01-01 – 2020-12-31 | 2032000 | USD | 20210317 | Open filing evidence |
| 2020-07-01 – 2020-09-30 | 619000 | USD | 20201112 | Open filing evidence |
| 2020-01-01 – 2020-09-30 | 1575000 | USD | 20201112 | Open filing evidence |
| 2020-04-01 – 2020-06-30 | 459000 | USD | 20200814 | Open filing evidence |
| 2020-01-01 – 2020-06-30 | 955000 | USD | 20200814 | Open filing evidence |
| 2020-01-01 – 2020-03-31 | 496000 | USD | 20200515 | Open filing evidence |
| 2019-01-01 – 2019-12-31 | 2910000 | USD | 20210317 | Open filing evidence |
| 2019-07-01 – 2019-09-30 | 594000 | USD | 20201112 | Open filing evidence |
| 2019-01-01 – 2019-09-30 | 2391000 | USD | 20201112 | Open filing evidence |
| 2019-04-01 – 2019-06-30 | 784000 | USD | 20200814 | Open filing evidence |
| 2019-01-01 – 2019-06-30 | 1797000 | USD | 20200814 | Open filing evidence |
| 2019-01-01 – 2019-03-31 | 1014000 | USD | 20200515 | Open filing evidence |
| 2018-01-01 – 2018-12-31 | 3098000 | USD | 20200324 | Open filing evidence |
Device · CART Xpress
Statement Business Segments · Subsegments
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=thmo:DeviceMember;us-gaap:SubsegmentsAxis=thmo:CARTXpressMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2020-01-01 – 2020-12-31 | 1828000 | USD | 20210317 | Open filing evidence |
| 2020-07-01 – 2020-09-30 | 425000 | USD | 20201112 | Open filing evidence |
| 2020-01-01 – 2020-09-30 | 1296000 | USD | 20201112 | Open filing evidence |
| 2020-04-01 – 2020-06-30 | 634000 | USD | 20200814 | Open filing evidence |
| 2020-01-01 – 2020-06-30 | 869000 | USD | 20200814 | Open filing evidence |
| 2020-01-01 – 2020-03-31 | 235000 | USD | 20200515 | Open filing evidence |
| 2019-01-01 – 2019-12-31 | 1565000 | USD | 20210317 | Open filing evidence |
| 2019-07-01 – 2019-09-30 | 918000 | USD | 20201112 | Open filing evidence |
| 2019-01-01 – 2019-09-30 | 1404000 | USD | 20201112 | Open filing evidence |
| 2019-04-01 – 2019-06-30 | 182000 | USD | 20200814 | Open filing evidence |
| 2019-01-01 – 2019-06-30 | 490000 | USD | 20200814 | Open filing evidence |
| 2019-01-01 – 2019-03-31 | 307000 | USD | 20200515 | Open filing evidence |
| 2018-01-01 – 2018-12-31 | 907000 | USD | 20200324 | Open filing evidence |
Device · Manual Disposables
Statement Business Segments · Subsegments
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=thmo:DeviceMember;us-gaap:SubsegmentsAxis=thmo:ManualDisposablesMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2020-01-01 – 2020-12-31 | 599000 | USD | 20210317 | Open filing evidence |
| 2020-07-01 – 2020-09-30 | 100000 | USD | 20201112 | Open filing evidence |
| 2020-01-01 – 2020-09-30 | 499000 | USD | 20201112 | Open filing evidence |
| 2020-04-01 – 2020-06-30 | 198000 | USD | 20200814 | Open filing evidence |
| 2020-01-01 – 2020-06-30 | 401000 | USD | 20200814 | Open filing evidence |
| 2020-01-01 – 2020-03-31 | 203000 | USD | 20200515 | Open filing evidence |
| 2019-01-01 – 2019-12-31 | 977000 Restated | USD | 20210317 | Open filing evidence |
| 2019-07-01 – 2019-09-30 | 221000 | USD | 20201112 | Open filing evidence |
| 2019-01-01 – 2019-09-30 | 764000 | USD | 20201112 | Open filing evidence |
| 2019-04-01 – 2019-06-30 | 242000 | USD | 20200814 | Open filing evidence |
| 2019-01-01 – 2019-06-30 | 543000 | USD | 20200814 | Open filing evidence |
| 2019-01-01 – 2019-03-31 | 300000 | USD | 20200515 | Open filing evidence |
| 2018-01-01 – 2018-12-31 | 976000 | USD | 20200324 | Open filing evidence |
Device · Other Subsegments
Statement Business Segments · Subsegments
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=thmo:DeviceMember;us-gaap:SubsegmentsAxis=thmo:OtherSubsegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2020-01-01 – 2020-12-31 | 351000 | USD | 20210317 | Open filing evidence |
| 2020-07-01 – 2020-09-30 | 42000 | USD | 20201112 | Open filing evidence |
| 2020-01-01 – 2020-09-30 | 315000 | USD | 20201112 | Open filing evidence |
| 2020-04-01 – 2020-06-30 | 282000 | USD | 20200814 | Open filing evidence |
| 2020-01-01 – 2020-06-30 | 316000 | USD | 20200814 | Open filing evidence |
| 2020-01-01 – 2020-03-31 | 34000 | USD | 20200515 | Open filing evidence |
| 2019-01-01 – 2019-12-31 | 73000 Restated | USD | 20210317 | Open filing evidence |
| 2019-07-01 – 2019-09-30 | 19000 | USD | 20201112 | Open filing evidence |
| 2019-01-01 – 2019-09-30 | 56000 | USD | 20201112 | Open filing evidence |
| 2019-04-01 – 2019-06-30 | 15000 | USD | 20200814 | Open filing evidence |
| 2019-01-01 – 2019-06-30 | 34000 | USD | 20200814 | Open filing evidence |
| 2019-01-01 – 2019-03-31 | 19000 | USD | 20200515 | Open filing evidence |
| 2018-01-01 – 2018-12-31 | 95000 | USD | 20200324 | Open filing evidence |